Abstract
The estrogen receptor (ER), an important drug target for the therapy of breast cancers, received a great deal of attention during recent years. This work aimed at finding more potent and selective ER modulators through the investigations of multiple ligand–receptor interactions by exploring the relationship between the experimental and predicted pIC50 values using in silico methods. A Bayesian-regularized neural network combined with principal component analysis has been conducted on a set of ER α modulators (127 molecules), resulting in the correlation coefficients of 0.91 ± 0.02, 0.87 ± 0.04 and 0.90 ± 0.02 for the training set (64 molecules), cross-validation set (32 molecules) and independent test (31 molecules), respectively. Meanwhile, a multiple linear regression (MLR) method has also been applied in order to explore the most important variables related to the biological activities. The proposed MLR model obtains a reasonable predictivity of pIC50 (R = 0.72, Q = 0.79) and makes use of four molecular descriptors, namely, Xvch6, nelem, SsssCH and SaaN. All these results prove the reliabilities of the in silico models, which should be useful not only for the screening but also for the rational design of novel ER α modulators with improved potency.
Similar content being viewed by others
References
Nilsson S, Gustafsson J-A (2002) Biological role of estrogen and estrogen receptors. Crit Rev Biochem Mol Biol 37: 1–28 doi:10.1080/10409230290771438
Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P et al (1986) Human estrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320: 134–139 doi:10.1038/320134a0
Ascenzi P, Bocedi A, Marino M (2006) Structure–function relationship of estrogen receptor α and β: impact on human health. Mol Aspects Med 27: 299–402 doi:10.1016/j.mam.2006.07.001
White INH (1999) The tamoxifen dilemma. Carcinogenesis 20: 1153–1160 doi:10.1093/carcin/20.7.1153
Maricic M, Gluck O (2002) Review of raloxifene and its clinical applications in osteoporosis. Expert Opin Pharmacother 3: 767–775 doi:10.1517/14656566.3.6.767
Miller CP (2002) SERMs: evolutionary chemistry, revolutionary biology. Curr Pharm Des 8: 2089–2111 doi:10.2174/1381612023393404
Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W et al (2001) Structure–activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem Res Toxicol 14: 280–294 doi:10.1021/tx000208y
Eertmans F, Dhooge W, Stuyvaert S, Comhaire F (2003) Comhaire endocrine disruptors: effects on male fertility and screening tools for their assessment. Toxicol In Vitro 17: 515–524 doi:10.1016/S0887-2333(03)00121-8
Ibarreta D, Daxenberger A, Meyer HH (2001) Possible health impact of phytoestrogens and xenoestrogens in food. APMIS 109: 161–184 doi:10.1034/j.1600-0463.2001.090301.x
Bryant HU (2002) Selective estrogen receptor modulators. Rev Endocr Metab Disord 3: 231–241 doi:10.1023/A:1020076426727
Jordan VC (2003) Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents. J Med Chem 46: 1081–1111 doi:10.1021/jm020450x
Meegan MJ, Lloyd DG (2003) Advances in the science of estrogen receptor modulation. Curr Med Chem 10: 181–210
Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O et al (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753–758 doi:10.1038/39645
MacGregor JI, Jordan VC (1998) Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev 50: 151–196
Hong H, Tong W, Fang H, Shi L, Xie Q, Wu J et al (2002) Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts. Environ Health Perspect 110: 29–36
Chen JJ, Tsai C-A, Moon H, Ahn H, Young JJ, Chen CH (2006) Decision threshold adjustment in class prediction. SAR QSAR Environ Res 17: 337–352 doi:10.1080/10659360600787700
Asikainen A, Kolehmainen M, Ruuskanen J, Tuppurainen K (2006) Structure–based classification of active and inactive estrogenic compounds by decision tree, LVQ and kNN methods. Chemosphere 62: 658–673 doi:10.1016/j.chemosphere.2005.04.115
Li H, Ung CY, Yap CW, Xue Y, Li ZR, Chen YZ (2006) Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. J Mol Graph Model 25: 313–323 doi:10.1016/j.jmgm.2006.01.007
Salum LB, Polikarpov I, Andricopulo AD (2007) Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies. J Mol Graph Model 26: 34–42 doi:10.1016/j.jmgm.2007.02.001
Chen HY, Dykstra KD, Birzin ET, Frisch K, ChanW, Yang YT et al (2004) Estrogen receptor ligands. Part 1. The discovery of flavanoids with subtype selectivity. Bioorg Med Chem Lett 14:1417–1421. doi:10.1016/j.bmcl.2004.01.031
Chen HY, Kim S, Wu JY, Birzin ET, Chan W, Yang YT et al (2004) Estrogen receptor ligands. Part 3. The SAR of dihydrobenzoxathiin SERMs. Bioorg Med Chem Lett 14 3: 2551–2554 doi:10.1016/j.bmcl.2004.02.084
Kim S, Wu J, Chen HY, Birzin ET, Chan W, Yang YT et al (2004) . Bioorg Med Chem Lett 14: 2741–2745 doi:10.1016/j.bmcl.2004.03.074
Kim S, Wu JY, Birzin ET, Frisch K, Chan W, Pai LY et al (2004) Estrogen receptor ligands II, Discovery of benzoxathiins as potent, selective estrogen receptor α modulators. J Med Chem 47: 2171–2175 doi:10.1021/jm034243o
Tan Q, Birzin ET, Chan W, Yang YT, Pai LY, Hayes EC et al (2004) Estrogen receptor ligands. Part 6. Synthesis and binding affinity of dihydrobenzodithiins. Bioorg Med Chem Lett 14: 3753–3755 doi:10.1016/j.bmcl.2004.04.101
Tan Q, Birzin ET, Chan W, Yang YT, Pai LY, Hayes EC et al (2004) Estrogen receptor ligands. Part 5. The SAR of dihydrobenzoxathiins containing modified basic side chains. Bioorg Med Chem Lett 14: 3747–3751 doi:10.1016/j.bmcl.2004.04.100
Tan Q, Blizzard TA, Morgan JD II, Birzin ET, Chan W, Yang YT et al (2005) Estrogen receptor ligands. Part 10. Chromanes: old scaffolds for new SERAMs. Bioorg Med Chem Lett 15: 1675–1681 doi:10.1016/j.bmcl.2005.01.046
Blizzard TA, DiNinno F, Morgan JD II, Wu JY, Chen HY, Kim S et al (2004) Estrogen receptor ligands. Part 8. Dihydrobenzoxathiin SERAMs with heteroatomsubstituted side chains. Bioorg Med Chem Lett 14: 3865–3868 doi:10.1016/j.bmcl.2004.05.073
Blizzard TA, DiNinno F, Morgan JD, Chen HY II, Wu JY, Gude C et al (2004) Estrogen receptor ligands. Part 7. Dihydrobenzoxathiin SERAMs with bicyclic amine side chains. Bioorg Med Chem Lett 14: 3664–3861
Blizzard TA, DiNinno F, Chen HY, Kim S, Wu JY, Chan W et al (2005) Estrogen receptor ligands. Part 13. Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain. Bioorg Med Chem Lett 15: 3912–3916 doi:10.1016/j.bmcl.2005.05.089
Blizzard TA, Dininno F, Morgan JD II, Chen HY, Wu JY, Kim S et al (2005) Estrogen receptor ligands. Part 9. Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers. Bioorg Med Chem Lett 15: 107–113 doi:10.1016/j.bmcl.2004.10.036
Wang Y, Li Y, Yang S-L, Yang L (2005) An in silico approach for screening flavonoids as P-glycoprotein inhibitors based on bayesian-regularized neural network. J Comput Aided Mol Des 19: 137–147 doi:10.1007/s10822-005-3321-5
Wang Y, Li Y, Yang S-L, Yang L (2005) Classification of substrates and inhibitors of P-Glycoprotein using unsupervised machine learning approach. J Chem Inf Comput Sci 45: 750–757 doi:10.1021/ci050041k
Wang Y, Li Y, Wang B (2007) An in Silico method for screening nicotine derivatives as cytochrome P450 2A6 selective inhibitors based on kernel partial least squares. Int J Mol Sci 8: 166– 179
Kier LB, Hall LH (1999) Molecular structure description: the electrotopological state. Academic Press, San Diego
Moriguchi I, Hirono S, Nakagome I, Hirano H (1994) Comparison of reliability of log P values for drugs calculated by several methods. Chem Pham Bull 42: 976–978
Hansch C, Leo A (1979) Substituent constants for correlation analysis in chemistry and biology. Wiley, New York
Alves CN, Pinheiro JC, Camargo AJ, Ferreira MMC, Romero RAF, da Silva ABF (2001) A multiple linear regression and partial least squares study of flavonoid compounds with anti-HIV activity. J Mol Struct THEOCHEM 541: 81–88 doi:10.1016/S0166-1280(00)00755-7
MacKay DJC (1992) Bayesian interpolation. Neural Comput 4: 415–447 doi:10.1162/neco.1992.4.3.415
MacKay DJC (1992) A practical bayesian framework for backprop networks. Neural Comput 4: 448–472 doi:10.1162/neco.1992.4.3.448
MacKay DJC (1995) Probable networks and plausible predictions-a review of practical Bayesian methods for supervised neural networks. Netw Comput Neural Syst 6: 469–505 doi:10.1088/0954-898X/6/3/011
Foresee FD, Hagan MT (1997) Gauss–Newton approximation to Bayesian regularization. Proceedings of the 1997 International Joint Conference on neural network 3: 1930–1935
Hagan MT, Menhaj MB (1994) Training feed forward networks with Marquardt algorithm. IEEE Trans Neural Netw 5: 989–993 doi:10.1109/72.329697
Nguyen D, Widrow B (1990) Improving the learning speed of 2-layer neural networks by choosing initial values of the adaptive weights. Proc Int Joint Conf Neural Netw 3: 21–26 doi:10.1109/IJCNN.1990.137819
Wold S, Esbensen K, Geladi P (1987) Principal component analysis. Chemom Intell Lab Syst 2: 37–52 doi:10.1016/0169-7439(87)80084-9
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
The Below is the Electronic Supplementary Material.
Rights and permissions
About this article
Cite this article
Wang, Y., Li, Y., Ding, J. et al. Prediction of binding affinity for estrogen receptor α modulators using statistical learning approaches. Mol Divers 12, 93–102 (2008). https://doi.org/10.1007/s11030-008-9080-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-008-9080-1